It appears the plasma of convalescent SARS patients may be effective in treating severe acute SARS patients, and suggests that SARS-CoV-1 IgG and/or IgM antibodies may represent passive immune antibodies capable of providing a protective or ameliorating effect against the invasion of the SARS-CoV-1. The gene discussed is CD40LG; the disease is severe acute respiratory syndrome.